Franklin Berger - Sep 21, 2021 Form 4 Insider Report for Kezar Life Sciences, Inc. (KZR)

Role
Director
Signature
/s/ Marc Belsky, Attorney-in-fact
Stock symbol
KZR
Transactions as of
Sep 21, 2021
Transactions value $
$170,269
Form type
4
Date filed
9/23/2021, 04:26 PM
Previous filing
Jun 30, 2021
Next filing
Mar 22, 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KZR Common Stock Options Exercise $52.6K +8.9K +1.13% $5.91* 793K Sep 21, 2021 Direct
transaction KZR Common Stock Options Exercise $67.9K +8.9K +1.12% $7.63* 802K Sep 21, 2021 Direct
transaction KZR Common Stock Options Exercise $49.8K +8.9K +1.11% $5.60 811K Sep 22, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KZR Stock Option (Right to Buy) Options Exercise $0 -8.9K -100% $0.00* 0 Sep 21, 2021 Common Stock 8.9K $5.91 Direct F1
transaction KZR Stock Option (Right to Buy) Options Exercise $0 -8.9K -100% $0.00* 0 Sep 21, 2021 Common Stock 8.9K $7.63 Direct F2
transaction KZR Stock Option (Right to Buy) Options Exercise $0 -8.9K -100% $0.00* 0 Sep 22, 2021 Common Stock 8.9K $5.60 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-hundred percent (100%) of the shares subject to the option vested on 1/1/2019.
F2 One-hundred percent (100%) of the shares subject to the option vested on 6/25/2020.
F3 One-hundred percent (100%) of the shares subject to the option vested on 6/24/2021.